Popular Folk Singer Sharda Sinha Dies At 72 After Battling Rare Blood Cancer

Sharda Sinha Death News: The famous folk singer died at the age 72 after battling multiple myeloma, a rare type of blood cancer.

Sharda Sinha Death News: Bihar's nightingale, and noted folk singer Sharda Sinha breathed her last on Tuesday, at 9.20 pm. She died due to refractory shock as a result of septicemia.

The renowned singer was admitted to Delhi's All India Institute of Medical Sciences (AIIMS) and has been undergoing treatment at the hospital's oncology department since October 25. As per reports, Ms Sinha has been suffering from multiple myeloma since 2017 - a form of cancer that affects the bone marrow. Ms Sinha was on a ventilator and died of refractory shock as a result of septicemia.

Multiple Myeloma: The Rare Blood Cancer That Killed Singer Sharda Sinha

Multiple myeloma is a rare form of blood cancer that targets plasma cells, which are vital for our immune system. These cells produce antibodies to combat infections. When someone has multiple myeloma, these malignant plasma cells grow uncontrollably, leading to severe health issues. This condition is also referred to as plasma cell myeloma or simply myeloma.

What Causes Multiple Myeloma?

While the precise cause of multiple myeloma is still uncertain, several risk factors have been identified. Age is a major factor, with most cases diagnosed in those over 65. Men are also more likely to develop this cancer compared to women. Additional risk factors include a family history of myeloma, certain infections, and environmental toxin exposure. Understanding these can contribute to better early detection and prevention strategies.

Symptoms of Multiple Myeloma

The symptoms of multiple myeloma can vary significantly among individuals, but common signs include

1. Bone pain
2. Fatigue
3. Frequent infections, and
4. Anemia

Patients may also face kidney issues and high calcium levels in their blood, leading to complications such as nausea and confusion. Identifying these symptoms early is essential for achieving timely diagnoses and treatments, which can significantly improve patient outcomes.